MedPath

SPIROGRASS Chewable Tablet 250mg

Registration Number: MAL06011731TCR

Approved
Approval ID

dfec4937ba098469

Registration Number

MAL06011731TCR

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (6)

100gm400Tablet TabletsAvailable
Package Size: 100gm400Tablet Tablets
Status: NPRA Approved
250gm1000Tablet TabletsAvailable
Package Size: 250gm1000Tablet Tablets
Status: NPRA Approved
200 gm800Tablet TabletsAvailable
Package Size: 200 gm800Tablet Tablets
Status: NPRA Approved
50 gm 200 Tablet TabletsAvailable
Package Size: 50 gm 200 Tablet Tablets
Status: NPRA Approved
30 gm 120 Tablet TabletsAvailable
Package Size: 30 gm 120 Tablet Tablets
Status: NPRA Approved
125 gm 500 Tablet TabletsAvailable
Package Size: 125 gm 500 Tablet Tablets
Status: NPRA Approved

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SPIROGRASS Chewable Tablet 250mg - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform